Suchergebnisse - "Wang, Weige"

PubPharm (33)

1

Orelabrutinib for the treatment of relapsed or refractory marginal zone lymphoma : A phase 2, multicenter, open-label study

enthalten in: American journal of hematology | 2023

von Deng, L. | Li, Z. | Zhang, H. | +30

2

METHODS OF TREATING DLBCL USING BTK INHIBITORS AND COMBINATIONS THEREOF

enthalten in: Europäisches Patentamt | 2023

von LIU YANG | WANG WEIGE | YAO HUI | +5

3

Pharmaceutical composition containing phosphoinositide 3-kinase inhibitor

enthalten in: Europäisches Patentamt | 2023

von CHEN ZHIHONG | YEO YONG-JIN | WANG WEIGE

4

Pharmaceutical composition containing phosphoinositide 3-kinase inhibitor

enthalten in: Europäisches Patentamt | 2023

von CHEN ZHIHONG | YEO YONG-JIN | WANG WEIGE

5

METHODS OF TREATING DLBCL USING BTK INHIBITORS AND COMBINATIONS THEREOF

enthalten in: Europäisches Patentamt | 2023

von YU YILING | LIU YANG | WANG WEIGE | +5

6

Orelabrutinib for the treatment of relapsed or refractory marginal zone lymphoma : A phase 2, multicenter, open‐label study

enthalten in: American Journal of Hematology | 2023

von Deng, L. | Li, Z. | Zhang, H. | +30

7

GANT61 suppresses cell survival, invasion and epithelial-mesenchymal transition through inactivating AKT/mTOR and JAK/STAT3 pathways in anaplastic thyroid carcinoma

enthalten in: Cancer biology & therapy | 2022

von Gao, H. | Wang, W. | Li, Q.

8

Methods of treating DLBCL using btk inhibitors and combinations thereof

enthalten in: Europäisches Patentamt | 2022

von YU YILING | LIU YANG | WANG WEIGE | +5

9

Methods of treating DLBCL using btk inhibitors and combinations thereof

enthalten in: Europäisches Patentamt | 2022

von YU YILING | LIU YANG | WANG WEIGE | +5

10

METHODS OF TREATING DLBCL USING BTK INHIBITORS AND COMBINATIONS THEREOF

enthalten in: Europäisches Patentamt | 2021

von YU YILING | LIU YANG | WANG WEIGE | +5